Drug recall D-0305-2020
Product
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10
Reason for recall
Presence of Foreign substance: identified as a dead ant.
Lots and codes
Lot #: F802345, F802346, F802347, Exp 11/20
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 30,516 bottles
- Distribution
- Product was distributed to major distributors/wholesalers throughout the United States.
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 1, 2019
- Terminated
- March 4, 2021
Related products
- Cefdinir – drug information
- NDC 68180-723 Cefdinir · Cefdinir 250 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-722 Cefdinir · Cefdinir 125 mg/5mL · Lupin Pharmaceuticals, Inc.